Article Sidebar
Published:
Jun 25, 2024Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Clinical effect of suspension training and Mulligan technique in combination with celecoxib in the treatment of chronic non-specific lower back pain
Abstract
Purpose: To investigate the clinical efficacy of suspension training and Mulligan technique in combination with celecoxib in the management of chronic lower back ache of unknown causes.
Methods: A total of 100 subjects with persistent lower back pain of unknown etiology treated in the Sports Medical Rehabilitation Center, Shijiazhuang, China from June 2019 to December 2020, were assigned at random to control and study cohorts (n = 50/group). Celecoxib (100 to 200 mg/day) was taken orally, once or twice daily by the control cohort, while the other cohort received suspension training, Mulligan technology (once a day, 8 weeks) and celecoxib. The treatment effect, pain and dysfunction scores, inflammatory indicators, quality of life, and complications were compared on Visual Analogue Scale (VAS) and Oswestry Disability Index (ODI).
Results: The effect of Macnab standard in study group was significantly better than that in control group (p < 0.05). After treatment, VAS and ODI scores in both cohorts were significantly lower than pretreatment values, but were significantly lesser in the study cohort. Furthermore, TNF-α level, and levels of CRP and IL-6 were significantly reduced when compared with pre-treatment levels, and were significantly lower in study cohort. The GQOL-74 scores in both groups were significantly increased after treatment, but were significantly lower in the control cohort (p < 0.05). No significant variations were seen in cases of complications between both cohorts.
Conclusion: The use of suspension training and Mulligan technology in combination with celecoxib in treating persistent lower back pain of unknown cause is beneficial in reducing lower back pain, mitigating dysfunction, and improving patients' quality of life. There is however a need for more studies to validate these findings.
